|
CRIM1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.87659887629366E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.02005120700733E-12 |
| Normal-vs-Stage2 |
2.29750000024787E-07 |
| Normal-vs-Stage3 |
1.13350000496837E-08 |
| Normal-vs-Stage4 |
1.446760E-04 |
| Stage1-vs-Stage2 |
7.590000E-01 |
| Stage1-vs-Stage3 |
8.393000E-01 |
| Stage1-vs-Stage4 |
8.135000E-01 |
| Stage2-vs-Stage3 |
6.408200E-01 |
| Stage2-vs-Stage4 |
9.896200E-01 |
| Stage3-vs-Stage4 |
7.256800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.87578899266828E-12 |
| Normal-vs-AfricanAmerican |
3.15949999496468E-08 |
| Normal-vs-Asian |
1.536130E-03 |
| Caucasian-vs-AfricanAmerican |
6.333000E-01 |
| Caucasian-vs-Asian |
8.207800E-01 |
| AfricanAmerican-vs-Asian |
9.633400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.64512847788956E-12 |
| Normal-vs-Female |
1.87778999999333E-05 |
| Male-vs-Female |
6.452200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.37080002904355E-09 |
| Normal-vs-Extreme_Weight |
2.66364708068068E-12 |
| Normal-vs-Obese |
3.63829999461274E-08 |
| Normal-vs-Extreme_Obese |
1.60199999998945E-06 |
| Normal_Weight-vs-Extreme_Weight |
9.061800E-01 |
| Normal_Weight-vs-Obese |
2.768200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.704600E-01 |
| Extreme_Weight-vs-Obese |
2.234000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.811200E-01 |
| Obese-vs-Extreme_Obese |
3.867400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.9801399999908E-05 |
| Normal-vs-Age(41-60Yrs) |
3.95150001608613E-09 |
| Normal-vs-Age(61-80Yrs) |
7.72160113626796E-13 |
| Normal-vs-Age(81-100Yrs) |
3.30240000001591E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.825400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.300400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.657600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.775600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.882800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.697600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.87738754834299E-12 |
| Normal-VS-Type2 PRCC |
2.44249065417534E-14 |
| Normal-VS-KIRP CIMP |
2.899700E-03 |
| Normal-VS-Unclassified PRCC |
8.789700E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.636200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.064800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.240400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.309600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.671870E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.277600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.86489720835448E-11 |
| Normal-vs-N1 |
1.54008999999622E-05 |
| Normal-vs-N2 |
7.988200E-04 |
| N0-vs-N1 |
1.659410E-01 |
| N0-vs-N2 |
8.766800E-01 |
| N1-vs-N2 |
6.075800E-01 |
|
|
